This Summer we welcomed Professor Guy Pratt to the Institute of Cancer and Genomics.
The Institute of Cancer and Genomic Sciences has three new Professors: Eva Petermann, Aga Gambus and Simon Bach.
New two year UK-wide study finds Covid-19 risk for cancer patients still higher than general population, but fell following availability of vaccinations in 2021
OCTAVE study reveals real-world vaccine response in patients with impaired immune systems
Zebrafish used to identify bone marrow failures in GATA2 deficiency that result in defective DNA repair and marrow failure
University of Birmingham set for renewal of pioneering Cancer Research Clinical Trials Unit which delivers more than 100 national and international trials
The Sarkar and Barrett labs have defined the molecular basis of neurodegeneration in Wolfram Syndrome patients carrying the WFS1 gene mutation.
NHS Cancer Programme funding will see an advanced test used at GP surgeries in the West Midlands to diagnose early-stage ovarian cancer.
Patients with aggressive brain tumours may be able to take part in a new trial of a cannabinoid-based drug, coordinated by the University of Birmingham.
Study showed that low levels of the MYB protein can be linked to the development of rare blood cancers.